A novel 4-gene signature for overall survival prediction in lung adenocarcinoma patients with lymph node metastasis

BACKGROUND: Lung adenocarcinoma (LUAD) patients experiencing lymph node metastasis (LNM) always exhibit poor clinical outcomes. A biomarker or gene signature that could predict survival in these patients would have a substantial clinical impact, allowing for earlier detection of mortality risk and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanfang, Zhang, Quanli, Gao, Zhaojia, Xin, Shan, Zhao, Yanbo, Zhang, Kai, Shi, Run, Bao, Xuanwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469135/
https://www.ncbi.nlm.nih.gov/pubmed/31015800
http://dx.doi.org/10.1186/s12935-019-0822-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469135/
https://www.ncbi.nlm.nih.gov/pubmed/31015800
http://dx.doi.org/10.1186/s12935-019-0822-1

Ejemplares similares